NTRB NutriBand Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1676047 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-37.3%
TTM net income YoY32.2%
TTM EPS YoY83.0%
Revenue 3-yr CAGR-10.8%
Net income 3-yr CAGR—
Margins
Gross margin33.1%
Operating margin-435.6%
Net margin-430.4%
FCF margin—
EBITDA margin-426.5%
Returns
ROE-100.7%
ROA-84.6%
ROIC (approx.)-326.9%
Asset turnover0.20x
Leverage & solvency
Liabilities / assets15.3%
Debt / equity0.00x
Current ratio4.21x
Interest coverage-339.35x
Cash quality & payout
Operating cash flow / net income0.52x
Accruals ratio-40.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-07-31 | 2027Q12026-04-30 | 2026Q4*2026-01-31 | 2026Q32025-10-31 | 2026Q22025-07-31 | 2026Q12025-04-30 | 2025Q4*2025-01-31 | 2025Q32024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $437,514 | $433,399 | $400,709 | $346,058 | $622,452 | $667,432 | $642,379 | $645,796 |
| Cost of revenue | $255,640 | $236,598 | $311,768 | $277,553 | $465,571 | $415,451 | $356,435 | $454,767 |
| Gross profit | $181,874 | $196,801 | $88,941 | $68,505 | $156,881 | $251,981 | $285,944 | $191,029 |
| R&D expense | $322,194 | $247,261 | $188,036 | $457,113 | $562,554 | $683,426 | $489,856 | $880,768 |
| SG&A expense | $750,317 | $1.20M | $921,820 | $3.49M | $1.60M | $982,052 | $1.76M | $737,102 |
| Operating income | -$890,637 | -$1.25M | -$1.02M | -$3.88M | -$2.00M | -$1.41M | -$5.56M | -$1.43M |
| Interest expense | $4,874 | $5,008 | $5,334 | $5,548 | $5,773 | $5,880 | $3,739 | $4,031 |
| Pretax income | -$880,561 | -$1.24M | -$968,059 | -$3.87M | -$2.00M | -$1.39M | -$5.52M | -$1.36M |
| Net income | -$880,561 | -$1.24M | -$968,059 | -$3.87M | -$2.00M | -$1.39M | -$5.52M | -$1.36M |
| EBITDA | -$857,311 | -$1.22M | -$985,036 | -$3.84M | -$1.95M | -$1.36M | -$5.49M | -$1.35M |
| EPS (basic) | -0.07 | -0.10 | — | -0.32 | -2.12 | -0.12 | — | -0.12 |
| EPS (diluted) | -0.07 | -0.10 | — | -0.32 | -2.12 | -0.12 | — | -0.12 |
| Weighted avg. shares (diluted) | 12.16M | 12.16M | — | 12.06M | 11.22M | 11.13M | — | 11.10M |
| Balance sheet | ||||||||
| Cash & equivalents | $3.42M | $4.01M | $4.57M | $5.31M | $7.00M | $2.96M | $4.31M | $5.70M |
| Receivables | $23,592 | $2,632 | $118,404 | $147,562 | $160,804 | $94,136 | $73,847 | $109,630 |
| Inventory | $170,733 | $121,494 | $117,987 | $135,998 | $138,031 | $215,324 | $212,041 | $168,299 |
| Current assets | $3.82M | $4.38M | $4.99M | $5.82M | $7.52M | $3.43M | $4.79M | $6.19M |
| PP&E, net | $530,085 | $548,244 | $567,255 | $587,968 | $615,857 | $658,073 | $695,063 | $739,630 |
| Goodwill | $1.72M | $1.72M | $1.72M | $1.72M | $1.72M | $1.72M | $1.72M | $5.02M |
| Intangibles | $170,094 | $185,261 | $200,427 | $215,593 | $230,760 | $245,926 | $261,092 | $582,418 |
| Total assets | $6.29M | $6.89M | $7.55M | $8.42M | $10.18M | $6.15M | $7.47M | $12.54M |
| Current liabilities | $907,048 | $832,137 | $784,281 | $772,524 | $1.57M | $925,051 | $982,845 | $1.25M |
| Total liabilities | $964,358 | $902,312 | $868,447 | $870,208 | $1.68M | $1.05M | $1.04M | $1.31M |
| Shareholders' equity | $5.33M | $5.99M | $6.68M | $7.55M | $8.49M | $5.10M | $6.43M | $11.23M |
| Shares outstanding | 12.16M | 12.16M | 12.16M | 12.17M | 12.02M | 11.13M | 11.07M | 11.11M |
| Cash flow statement | ||||||||
| Operating cash flow | -$584,999 | -$563,104 | -$731,830 | -$1.75M | -$1.31M | -$1.34M | -$1.24M | -$1.01M |
| Capital expenditure | — | — | $0 | $0 | $0 | $5,324 | $0 | $46,958 |
| Free cash flow | — | — | -$731,830 | -$1.75M | -$1.31M | -$1.34M | -$1.24M | -$1.06M |
| Investing cash flow | — | — | $0 | $0 | $0 | -$5,324 | $0 | -$46,958 |
| Financing cash flow | $430 | -$5,569 | -$5,490 | $69,563 | $5.34M | -$5,324 | -$147,224 | -$5,175 |
| Depreciation & amortization | $33,326 | $34,177 | $35,879 | $42,956 | $57,382 | $57,480 | $72,855 | $73,149 |
| Stock-based compensation | — | $552,458 | $98,513 | — | — | — | $855,600 | $0 |
Free plan shows the latest 8 periods; Pro shows all 44 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.